The E3 ubiquitin ligase HUWE1 is required for KRAS-induced lung cancer.
Saved in:
| Title: | The E3 ubiquitin ligase HUWE1 is required for KRAS-induced lung cancer. |
|---|---|
| Authors: | Searle J; Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK. Joshua.searle@ucl.ac.uk.; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK. Joshua.searle@ucl.ac.uk.; Lungs for Living Research Centre, UCL Respiratory, Division of Medicine, University College London (UCL), London, UK. Joshua.searle@ucl.ac.uk., Menotti M; Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK.; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK., McDaid WJ; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK.; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK., Baker MJ; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK.; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK., Chaturvedi A; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK.; The Christie NHS Foundation Trust, Manchester, UK., Ginn L; Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK.; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK., Reed H; Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK.; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK., Carter M; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK.; The Christie NHS Foundation Trust, Manchester, UK., Blackhall F; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK.; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.; The Christie NHS Foundation Trust, Manchester, UK., Lindsay CR; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK.; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.; The Christie NHS Foundation Trust, Manchester, UK., Malliri A; Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK. angeliki.malliri@manchester.ac.uk.; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK. angeliki.malliri@manchester.ac.uk.; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK. angeliki.malliri@manchester.ac.uk. |
| Source: | Cell death & disease [Cell Death Dis] 2026 Apr 07; Vol. 17 (1). Date of Electronic Publication: 2026 Apr 07. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41942468 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The E3 ubiquitin ligase HUWE1 is required for KRAS-induced lung cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Searle+J%22">Searle J</searchLink>; Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK. Joshua.searle@ucl.ac.uk.; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK. Joshua.searle@ucl.ac.uk.; Lungs for Living Research Centre, UCL Respiratory, Division of Medicine, University College London (UCL), London, UK. Joshua.searle@ucl.ac.uk.<br /><searchLink fieldCode="AU" term="%22Menotti+M%22">Menotti M</searchLink>; Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK.; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22McDaid+WJ%22">McDaid WJ</searchLink>; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK.; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Baker+MJ%22">Baker MJ</searchLink>; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK.; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Chaturvedi+A%22">Chaturvedi A</searchLink>; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK.; The Christie NHS Foundation Trust, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Ginn+L%22">Ginn L</searchLink>; Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK.; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Reed+H%22">Reed H</searchLink>; Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK.; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Carter+M%22">Carter M</searchLink>; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK.; The Christie NHS Foundation Trust, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Blackhall+F%22">Blackhall F</searchLink>; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK.; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.; The Christie NHS Foundation Trust, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Lindsay+CR%22">Lindsay CR</searchLink>; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK.; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.; The Christie NHS Foundation Trust, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Malliri+A%22">Malliri A</searchLink>; Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK. angeliki.malliri@manchester.ac.uk.; Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK. angeliki.malliri@manchester.ac.uk.; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK. angeliki.malliri@manchester.ac.uk. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101524092%22">Cell death & disease</searchLink> [Cell Death Dis] 2026 Apr 07; Vol. 17 (1). <i>Date of Electronic Publication: </i>2026 Apr 07. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101524092 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-4889 (Electronic) <i>NLM ISO Abbreviation: </i>Cell Death Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41942468 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41419-026-08672-7 Languages: – Code: eng Text: English Titles: – TitleFull: The E3 ubiquitin ligase HUWE1 is required for KRAS-induced lung cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Searle J – PersonEntity: Name: NameFull: Menotti M – PersonEntity: Name: NameFull: McDaid WJ – PersonEntity: Name: NameFull: Baker MJ – PersonEntity: Name: NameFull: Chaturvedi A – PersonEntity: Name: NameFull: Ginn L – PersonEntity: Name: NameFull: Reed H – PersonEntity: Name: NameFull: Carter M – PersonEntity: Name: NameFull: Blackhall F – PersonEntity: Name: NameFull: Lindsay CR – PersonEntity: Name: NameFull: Malliri A IsPartOfRelationships: – BibEntity: Dates: – D: 07 M: 04 Text: 2026 Apr 07 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2041-4889 Numbering: – Type: volume Value: 17 – Type: issue Value: 1 Titles: – TitleFull: Cell death & disease Type: main |
| ResultId | 1 |